| Endometriosis |
1 |
1 |
| Pain |
0 |
0.82 |
| Pelvic Pain |
0 |
0.9 |
| Pain Management |
0 |
0.62 |
| Progestin |
0 |
0.24 |
| Gonadotropin-Releasing Hormone (GnRH) Antagonist |
0 |
0.75 |
| Surgery |
0 |
0.21 |
| Adverse Effects |
0 |
0.15 |
| Contraception |
0 |
0.75 |
| Patient Safety |
0 |
0.1 |
| Dysmenorrhea |
0 |
0.9 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.09 |
| Infertility |
0 |
0.09 |
| Ultrasonography |
0 |
0.09 |
| Infertility Female |
0 |
0.07 |
| Clinical Research |
0 |
0.06 |
| Dorsum |
0 |
0.06 |
| In Vitro Fertilization |
0 |
0.06 |
| Reproductive Medicine |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.04 |
| Reproductive Endocrinology |
0 |
0.04 |
| Abdominal Bloating |
0 |
0.03 |
| Adhesion |
0 |
0.03 |
| Bladder |
0 |
0.03 |
| Board Certification |
0 |
0.03 |
| Bone |
0 |
0.03 |
| Breast |
0 |
0.03 |
| Caregiver |
0 |
0.03 |
| Connecticut |
0 |
0.03 |
| Endocrinology |
0 |
0.03 |
| Endometrioma |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Jobs |
0 |
0.03 |
| Laparoscopy |
0 |
0.03 |
| Pregnancy |
0 |
0.03 |
| Steroids |
0 |
0.03 |
| Tumor |
0 |
0.03 |
| Uterus |
0 |
0.03 |
| Medical Life |
0 |
0.02 |
| Menopause |
0 |
0.02 |
| Stem Cell Research and Therapy |
0 |
0.02 |